CytoSorbents: Q2 Earnings Snapshot

In this article:

PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $6.2 million in its second quarter.

On a per-share basis, the Princeton, New Jersey-based company said it had a loss of 14 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The blood purification therapy company posted revenue of $9.4 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $11 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO

Advertisement